Clinical Trial Update: Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating allogenic mesenchymal stem cells from umbilical cord for osteoporosis, focusing on clinical and bone density improvements.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Allogenic mesenchymal stem cells from umbilical cord

Snippet

Sponsor: Ahmad Jabir Rahyussalim | Conditions: Osteoporosis | Phase 2 | Status: UNKNOWN